Onconetix boosts interim CEO pay; shareholders OK PIPE issuance for up to 12.8M shares

Onconetix, Inc.

Interim CEO Karina Fedasz receives $45,000 bonus for 2025, payable Jan 2026; base comp increased $5,000/month from Jan 1, 2026.
Annual meeting elects Thomas Meier and Sarah Romano as Class I directors for three-year term.
Shareholders approve PIPE proposals enabling up to ~12.8M shares from Series D (8.8M) and Series E (4.0M) preferred/warrants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.